Steve Tomlin Consultant Pharmacist – Children’s Services

Slides:



Advertisements
Similar presentations
ROLE OF A PHARMACIST IN IMPROVING THE QUALITY OF TREATMENT IN INPATIENTS Sabina Farooq* Dr Shobarani R H, Dr Venugopal Reddy, Geetha pradeep, Soumya k.L.
Advertisements

Engaging the C-suite to Advance Pharmacy Practice Providing quality patient care through progressive pharmacy practice Ensuring the Accuracy of the Medication.
Safe Supply of Paediatric Unlicensed Medicines
FACTORS HINDERING ATTITUDE TO TREATMENT AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS IN THE NIGER DELTA, NIGERIA by AGOFURE OTOVWE and OYEWOLE OYEDIRAN.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Potentially inappropriate prescribing and.
Brock Delfante Pharmacist Sir Charles Gairdner Hospital
Clinical Pharmacist Intervention in Cardiac Patients With Renal Impairment Elham Al-Shammari, B.Sc. Pharm. Hisham Abou-Auda, Ph. D. Meshal Al-Mutairi,
Improving prescribing quality Richard Seal Programme Director National collaborative medicines management services programme.
S urgical P re A dmission R eview C linics (SPARC) Truc Nguyen Pharmacy Surgical Team Leader CMH Pharmacy.
RESEARCH POSTER PRESENTATION DESIGN © Dr Noa Keren, Dr Laura Haynes, Dr Rosanna Bevan, Dr Reena Bhatt, Steve Tomlin, Dr.
Wimon Anansakunwatt, Uraiwan Silpasupagornwong, Umporn Yoobang, Naruemon Dhana, Monwarat Laohajeeraphan INTERVENTIONS TO IMPROVE MEDICATION SAFETY IN A.
Measuring the Severity of Medication Discrepancies: A Community Pharmacy Perspective.
Chaos Waiting for Bad Luck? Medication Reconciliation Should Be Mandatory * Clinical Pharmacist, Pharmacy Division Supported by a joint non-restricted.
Evaluation of a Pharmacist-conducted Medication Reconciliation Program upon Admission in a Medical Center in Taiwan Yen-Ying Lee, M.S., PharmD 1,2, Tzu-Ying.
Amany M. Shebl Professor Of Medical-surgical Nursing Dean. Nursing Faculty, Mansoura University, Egypt.
Event Analysis Lessons learnt from Medication Reconciliation activities using Event Analysis to improve medication safety Evonne Fong, Dale Mitchell, Stephen.
Medicines optimisation – a research pharmacist’s perspective Dr David Alldred Senior Lecturer in Pharmacy Practice 23 January 2015Bradford School of Pharmacy1.
Pharmacist’s Role in Transitions of Care
Self-assessment Accuracy: the influence of gender and year in medical school self assessment Elhadi H. Aburawi, Sami Shaban, Margaret El Zubeir, Khalifa.
Controlling “Polypharmacy” in the elderly The “Medication Appropriateness Index” G. Vital-Durand 1, F. Herrmann 2, J-P. Michel 2, V. Rollason 3, N. Vogt.
A retrospective evaluation of errors involving oral chemotherapy at Brighton and Sussex University Hospitals NHS Trust Emma Foreman, Simon Matthews and.
Is avoidable mortality a good measure of the quality of hospital care? Dr Helen Hogan Clinical Senior Lecturer in Public Health London School of Hygiene.
Clinical errors - their causes and frequency in hospitals Prof Johanna Westbrook Prof Enrico Coiera Funded by: HCF Health & Medical Research Foundation.
Critical Appraisal (CA) I Prepared by Dr. Hoda Abd El Azim.
Using a Novel Two-Pronged Pharmacy Model in a High-Risk Care Management Program to Address Medication Reconciliation and Access Kakoza RM 1, 2, De Leon.
Is avoidable mortality a good measure of the quality of healthcare? Dr Helen Hogan Clinical Senior Lecturer in Public Health London School of Hygiene and.
Introducing ePMA into a Paediatric ITU Will Hall - Lead Pharmacist for ePMA.
Medication Reconciliation: Spread to MSNU & 4 West Pre- Admit Clinic.
Methotrexate Never Event Presentation Date November 2015 Christine Dodd Medication Safety Pharmacist Martin Shepherd Medicines Information & Clinical Economy.
Patient Population Nursing-Pharmacy Collaboration on Medication Reconciliation: A Novel Approach to Information Management Michelle Silas MPH, BSN, RN,
Intrathecal Morphine Usage in Hepatobiliary Surgery Dr David Cosgrave Dr Era Soukhin Dr Anand Puttapa Dr Niamh Conlon.
Comparison of pharmacy technician versus nurse obtained medication histories in the emergency department Marija Markovic, Pharm.D. PGY-1 Pharmacy Practice.
Intervention to minimise medication error on admission and discharge Medication Reconciliation Tamasine Grimes PhD, MPSI Research Pharmacist, AMNCH Associate.
Authors: Michael Lloyd, Dr. Simon Watmough, Prof. Sarah O’Brien, Prof
Pharmacist Interventions and Healthcare Utilization and Cost
Medication Safety Alice Roueché: Consultant Paediatrician
CLINICAL AUDIT Drug Prescribing for ADHD in Children
Mike Caulfield MSc, PGCE, BSc, DipHE
BELIEFS, ATTITUDES AND KNOWLEDGE ABOUT DIABETES MELLITUS AMONG PATIENTS ATTENDING A GENERAL MEDICAL CLINIC: A DESCRIPTIVE CASE CONTROLLED STUDY K M.
The Plasma Concentrations of Atorvastatin and its Active Metabolites in Relation to the Dose in Stable Coronary Artery Disease Patients at a Tertiary Referral.
Tait J1, Thomson K1, Kinnear M1,2, Souter C1,2, Akram G2
Job Satisfaction and Its Determinants Among Health Staffs in An Lao District Hospital, Hai Phong Tran Thi Thuy Ha Haiphong University of Medecine and Pharmacy,
Audit Opioid use in palliative patients on general hospital wards
Figure 1. Onset of PIV catheter complications
The potential for pharmacists to manage young patients attending Emergency Departments - UK David Terry1,2, Chi Huynh1, Konstantinos Petridis3, Matt Aeillo4,
Research experience and challenges
PICU Pharmacist Interventions: what can they tell us?
“Medicines Reconciliation” Audit
Effectiveness of Care Measures
Training package is appropriate
@Improve_Academy #WeStopMeds.
Polypharmacy In Adults: Small Test of Change
Does the Beer’s Criteria Influence Prescribing for Geriatric Patients?
Reducing Medication Errors with ePMA: 7 Years Experience
Prescribing Errors in Paediatrics
Dr Nikki Coghill1,2, Dr Ludivine Garside1, Amanda Chappell 3
Accepted 2 June Ryan Chen
Victoria Gemmell1 Professor Alex Mullen2
The Research Question Aims
Disclosure belangen NHG spreker
The clinical significance of medication reconciliation (MR) in children admitted to hospital: development & evaluation of pharmacy led admission services.
Critical Care Outreach Medway
WHO Community drug use practices in malaria in Cambodia: a cross-sectional study National Malaria Centre of Cambodia Rational Pharmaceutical Management.
The Research Question Does changing prescription medication labels to conform to the United States Pharmacopeia (USP) patient-centered, more understandable,
Evidence Based Practice
Clair Huckerby Consultant Pharmacist
Nahedh Rashed Alotaibi and Nesreen Al-Shubbar
Pharmacy Technician Led Accident and Emergency Pharmacy Service
Chaos Waiting for Bad Luck
Presentation transcript:

Steve Tomlin Consultant Pharmacist – Children’s Services Evaluation of a service to resolve drug-related problems in children admitted to hospital Steve Tomlin Consultant Pharmacist – Children’s Services Evelina Children’s Hospital Pharmacy Department

Introduction A Drug-Related Problem is defined as “an event or circumstance involving drug therapy that actually or potentially interferes with desired health outcomes”1 DRPs are common and a major cause for harm and costs in hospitals. DRPs is up to 25% in inpatients (adult).2 DRPs were reported to be associated with 3-16% of hospital admission (adult).3 92% were probably preventable.3 The size of DRPs in children in the UK is relatively unknown Pharmaceutical Care Network Europe 2008. http://www.pcne.org/ (accessed on 06/12/2008). Koh Y, Kutty FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag 2005; 1(1):39-48.  Zargarzadeh AH, Emami MH, Hosseini F. Drug-related hospital admissions in a generic pharmaceutical system 1. Clin Exp Pharmacol Physiol 2007; 34(5-6):494-8.

Aim and objective To identify the incidence and type of DRPs in children admitted to hospital or attending A&E in a large UK teaching hospital Trust. To investigate causes of DRPs in children. To evaluate the effectiveness and cost of a service providing pharmacy support to reduce the problem

Methodology Observational study including patients aged 0-18 years Admitted to medical, surgical, PICU, and NICU wards or attending the A&E department at the study hospital 3 month data collection DRPs validated by a panel: consultant paediatrician clinical pharmacist researcher Score the validated DRPs in terms of potential patient outcomes on a validated scale (Dean & Barber model)* * Dean BS, Barber ND. A validated, relaiable method of scoring the severity of medication errors. Am J Health Syst Pharm 1999;56 (1): 57-62

Statistical Plan Descriptive analysis was conducted on the study demographics and DRPs using SPSS. The incidence of the DRPs was calculated with 95% CI. It is defined as number of patients with at least one DRP per total patients reviewed and multiplied by 100. Logistic regression to explore risk factors for DRPs Data will be analysed with respect to how many DRPs were identified and actions taken by the pharmacist. This will be related to the time the pharmacist spent reviewing patients and issuing recommendations for resolving DRPs

Demographic Results Total A&E Medical NICU PICU Number of pt 110 273 Ward Total A&E Medical NICU PICU Number of pt 110 273 50 483 Patient with DRP (%) 14 (12.7) 93 (34.1) 24 (48) 30 (60) 161 (33.3) Gender; n(%) Female 42 (38.2) 104 (38.1) 23 (46) 193 (39.9) Male 68 (61.2) 169 (61.9) 26 (52) 27 (54) 290 (60.0) No. of DRP (%) 17 (7.2) 143 (60.3) 28 (11.8) 49 (20.7) 237 (100) Age in group 0-1y 27 113 35 225 1-3y 18 32 10 60 >3y-≤6y 24 31 2 57 7y-12y 29 41 1 71 >12y-≤18y 12 56 70

Overall DRP Incidence 33.3% (95% CI; 29.1-37.7) Average time spent on evaluation and intervention for 237 DRPs: 12.7 minutes (SE ±1.5, 95%CI; 9.7-15.7) Overall mean age 4.3 years (95%CI; 3.8-4.7)

Cause of DRP Cause of DRP Number of cases % Drug or Dose Selection 70 29.5 Drug Use Process 26 10.9 Information 34 14.3 Patient/Psychological 16 6.8 Logistics 73 30.8 Others 12 5.1

Type of Intervention Type of intervention Number of cases % No intervention 19 8.0 Intervention at prescriber level 109 45.9 Intervention at patient/carer level 21 8.9 Intervention at drug level 125 52.7 Other 26 10.9

Examples A&E – propranolol liquid strength A&E – 100mg Viagra for a 3 yrs & 2 month old Medical – morphine infusion led to HDU Medical – 4 x dose of clindamicin A&E – Pen V (blanching trunk and vomiting) PICU – Fentanyl mg vs mcg (x2!!!!) Medical = Valproate – parents understanding

Loads to do Comparison of data with other centres Real role and cost of the pharmacist in preventing DRPs Value of pharmacist in A&E? Align data with Reconciliation data PUBLISH in early 2011

Thanks & Questions ASIA RASHED ECH pharmacy staff Prof Ian Wong Dr J Jackman NPPG & Man Med ASIA RASHED